A Study of QLP2117 in Combination With QL2107 in Advanced Solid Tumor Patients
Clinical trial NCT06911827 · RECRUITING
Trial details
- NCT number
- NCT06911827
- Sponsor
- Qilu Pharmaceutical Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-09
- Primary completion
- 2027-12-01
- Enrollment
- 149
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.